期刊文献+

莫诺苯宗联合咪喹莫特对C57BL6小鼠白癜风造模的作用研究 被引量:2

Effect of monobenzone combined with imiquimod to the C57BL6 mice vitiligo
在线阅读 下载PDF
导出
摘要 目的:探讨莫诺苯宗联合咪喹莫特对C57BL6小鼠白癜风造模的作用,以构建稳定、效果佳的白癜风模型,为治疗白癜风的药理、药效及机制研究奠定基础。方法:将30只4周龄的C57BL6小鼠分为A、B、C共3组,分别予A组40%莫诺苯宗联合5%咪喹莫特、B组40%莫诺苯宗、C组5%咪喹莫特涂搽小鼠下背部,每组每日涂药1次,连续涂搽60天。另取5只C57BL6小鼠为阴性对照组,不予任何处理。结果:A组与B组涂药2周后涂药部位均出现色素脱失,两组开始脱色的时间比较,差异无统计学意义(t=1. 23,P> 0. 05),但2个月后两组涂药部位脱色积分比较,差异有统计学意义(t=2. 43,P <0. 05); A组非涂药部位色素脱失情况较B组相比,差异有统计学意义(t=2. 45,P <0. 05); C组仅可见1只小鼠涂药部位出现少量脱色。阴性对照组见未脱色及脱毛。结论:莫诺苯宗联合咪喹莫特对C57BL6小鼠白癜风造模的效果优于莫诺苯宗或咪喹莫特单独使用组。 Objective:To investigate the effect of monobenzone combined with imiquimod on the vitiligo in C57BL6 mice model , and to establish a stable and effective model of vitiligo, which is important for the research of pharmacological, pharmacodynamic and mechanism on vitiligo. Methods: 30 four-week-old C57BL6 mice were divided into three groups: A, B, and C. 40% monobenzone in combination with 5% imiquimod were given in group A, 40% monobenzone were given in group B, and 5% imiquimod were given in group C. Each group continue to apply on the low back once a day, for 60 days. Another 5 C57BL6 mice were used as a negative control group without any treatment. Results: After 2 weeks of application, group A and group B showed hypopigmentation on the site of application. There was no statistical significant in the duriation of decolorization between the two groups (t=1.23,P>0.05). There was a statistically significant in decolorization scores of the applied parts after 2 months (t=2.43,P<0.05). The hypopigmentation in non-applied area of the group A was statistical significance different with that in group B (t=2.45,P<0.05);only a small amount of discoloration appeared in treatment area of 1 mouse in group C. The negative control group showed no discoloration or hair revmoval. Conclusion:Monobenzone combined with imiquimod is superior to monobenzone or imiquimod in treatment of vitiligo for C57BL6 mice.
作者 王天晶 李里 张婷 张佳林 罗光浦 WANG Tian-jing;LI Li;ZHANG Ting;ZHANG Jia-lin;LUO Guang-pu(Dermatology Hospital of Southern Medical University,Guangzhou 510091,China)
出处 《皮肤性病诊疗学杂志》 2018年第6期321-324,共4页 Journal of Diagnosis and Therapy on Dermato-venereology
基金 广东省医学科学技术研究基金(编号:A2015228)
关键词 莫诺苯宗 咪喹莫特 C57BL6小鼠 白癜风模型 monobenzone imiquimod C57BL6 mice vitiligo model
作者简介 通信作者:罗光浦,E-mail:102931@163.com.
  • 相关文献

参考文献3

二级参考文献26

  • 1刘璋,胡佑伦,韩瑞玲.黑素生成过程中黄芩的调节作用[J].武汉大学学报(医学版),2005,26(1):66-67. 被引量:12
  • 2邓剑,向成玉,邓正华.白癜风患者血清及负压吸引疱疱液IL-18和IFN-γ的检测[J].中国现代医学杂志,2005,15(21):3271-3272. 被引量:4
  • 3武荣兰,封顺,王吉德.黄芩苷及其金属配合物的抗氧性研究[J].科技导报,2006,24(2):36-38. 被引量:24
  • 4Laddha NC, Dwivedi M, Mansuri MS, et al. Association of neuropeptide Y ( NPY), interleukin-1B ( ILl B) genet- ic variants and correlation of IL1B transcript levels with vitiligo susceptibility [ J/OL ]. PLoS One, 2014,9 ( 9 ) : e107020 [ 2015-09-28 ]. http://journals, plos. org/ plosone/article? id = 10. 1371/journal. pone. 0107020.
  • 5Li P, Ma H, Han D, et al. Interleukin-33 affects cyto- kine production by keratinocytes in vitiligo [ J ]. Clin Exp Dermato1,2015,40(2) : 163-170.
  • 6Tembhre MK, Sharma VK, Sharma A, et al. T helper and regulatol7 T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo [ J ]. Clin Chim Acta,2013 ,424 :27-32.
  • 7Imran M, Laddha NC, Dwivedi M, et al. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo[ J]. Br J Dermatol,2012, 167(2) :314-323.
  • 8Yao L, Hu DN, Chen M, et al. Subtoxic levels hydrogen peroxide-induced expression of interleukin-6 by epidermal melanocytes [ J ]. Arch Dermatol Res, 2012,304 (10) : 831-838.
  • 9Passeron T, Ortonne JP. Activation of the unfolded pro- tein response in vitiligo: the missing link? [ J]. J Invest Dermato1,2012,132( 11 ) :2502-2504.
  • 10Vaccaro M, Cannavo SP, Imbesi S, et al. Increased ser- um levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo [ J ]. Int J Dermatol, 2015,54(6) :672-674.

共引文献28

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部